Cranbury, NJ, United States of America

Alan R Shaw

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 6.3

ph-index = 3

Forward Citations = 115(Granted Patents)


Location History:

  • Doylestown, PA (US) (1998 - 2002)
  • Cranbury, NJ (US) (2015)
  • Doyelstown, PA (US) (2015)

Company Filing History:


Years Active: 1998-2015

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: **Alan R. Shaw: Innovator in Affinity Chromatography and Transgenic Solutions**

Introduction

Alan R. Shaw is a renowned inventor based in Doylestown, Pennsylvania, who has made significant contributions to the field of biotechnology. With a focus on innovations that drive advancements in purification processes and genetic engineering, Shaw holds a total of two patents that illustrate his expertise in these areas.

Latest Patents

Shaw's latest patents include a groundbreaking method for large scale affinity chromatography of macromolecules. This process outlines a novel approach for purifying target molecules by selecting ligands based on real-time identification of association and dissociation constants. This innovative method involves anchoring ligands to a solid support, which allows for the efficient removal of low affinity target molecules and the elution of particularly pure target molecules.

Another significant patent by Shaw is focused on the expression of human interleukin-1 beta in a transgenic animal. This advancement signifies a substantial step forward in biopharmaceutical production, highlighting his commitment to enhancing medical solutions through genetic technology.

Career Highlights

Alan R. Shaw is currently employed at Merck & Company, Inc., where he continues to work on cutting-edge research that bridges the gap between science and practical applications. His career at Merck is marked by numerous contributions to projects that align with the company's mission to deliver innovative health solutions worldwide.

Collaborations

Shaw has collaborated with esteemed colleagues like Howard Y. Chen and Kathryn J. Hofmann. These partnerships have played a vital role in driving research initiatives, leading to successful patent applications and innovative solutions within the pharmaceutical landscape.

Conclusion

Alan R. Shaw stands out as a visionary inventor whose patents in affinity chromatography and transgenic technology reflect his dedication to advancing biomedical sciences. His collaborative spirit and commitment to innovation will undoubtedly continue to shape the future of biotechnology and medicine for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…